283.5K XNAS Volume
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Brent Hatzis-Schoch | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 75,000 | 83,400 (0%) | 0% | 0 | Common Stock | |
| Brent Hatzis-Schoch | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Sergey Yurasov | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Sergey Yurasov | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 75,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
| Mark A. Velleca | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 75,000 | 121,522 (0%) | 0% | 0 | Common Stock | |
| Mark A. Velleca | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 75,000 | 170,192 (0%) | 0% | 0 | Common Stock | |
| Erika Jones | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 75,000 | 85,150 (0%) | 0% | 0 | Common Stock | |
| Erika Jones | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 2.50 per share. | 13 Dec 2024 | 5,750 | 63,334 (0%) | 0% | 2.5 | 14,375 | Common Stock |
| Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 2.50 per share. | 13 Dec 2024 | 5,150 | 10,145 (0%) | 0% | 2.5 | 12,875 | Common Stock |
| Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 2.50 per share. | 13 Dec 2024 | 4,500 | 8,865 (0%) | 0% | 2.5 | 11,250 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 4.78 per share. | 20 Sep 2024 | 3,007 | 57,584 (0%) | 0% | 4.8 | 14,373 | Common Stock |
| Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 4.78 per share. | 20 Sep 2024 | 2,694 | 4,995 (0%) | 0% | 4.8 | 12,877 | Common Stock |
| Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 4.78 per share. | 20 Sep 2024 | 2,354 | 4,365 (0%) | 0% | 4.8 | 11,252 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 4.98 per share. | 21 Jun 2024 | 2,887 | 54,577 (0%) | 0% | 5.0 | 14,377 | Common Stock |
| Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 4.98 per share. | 21 Jun 2024 | 2,301 | 2,301 (0%) | 0% | 5.0 | 11,459 | Common Stock |
| Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 4.98 per share. | 21 Jun 2024 | 2,011 | 2,011 (0%) | 0% | 5.0 | 10,015 | Common Stock |
| Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| Garry E. Menzel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| Samarth Kulkarni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,550 | 30,550 | - | - | Stock Option (Right to Buy) | |
| Prakash Raman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 61,100 | 61,100 | - | - | Stock Option (Right to Buy) | |
| Shannon Campbell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 61,100 | 61,100 | - | - | Stock Option (Right to Buy) | |
| Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 4.54 per share. | 15 Mar 2024 | 3,253 | 38,054 (0%) | 0% | 4.5 | 14,769 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 4.54 per share. | 15 Mar 2024 | 3,166 | 51,690 (0%) | 0% | 4.5 | 14,374 | Common Stock |
| Brent Hatzis-Schoch | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Jones Erika | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Yurasov Sergey | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Ni Fang | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Velleca Mark A. | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 537,000 | 537,000 | - | - | Stock Option (Right to Buy) | |
| Behbahani Ali | Director | Grant, award, or other acquisition of securities at price $ 2.73 per share. | 15 Dec 2023 | 4,455 | 48,524 (0%) | 0% | 2.7 | 12,162 | Common Stock |
| L. Dixon Wendy | Director | Grant, award, or other acquisition of securities at price $ 2.73 per share. | 15 Dec 2023 | 4,043 | 34,801 (0%) | 0% | 2.7 | 11,037 | Common Stock |
| Ali Behbahani | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 05 Jul 2023 | 1,000,000 | 4,448,757 (12%) | 2% | 5 | 5,000,000 | Common Stock |
| David M. Epstein | Director, SEE REMARKS | Sale of securities on an exchange or to another person at price $ 6.70 per share. | 27 Jun 2023 | 25,000 | 671,423 (1%) | 0% | 6.7 | 167,500 | Common Stock |
| Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 2.10 per share. | 16 Jun 2023 | 5,119 | 27,772 (0%) | 0% | 2.1 | 10,750 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 2.10 per share. | 16 Jun 2023 | 5,655 | 40,770 (0%) | 0% | 2.1 | 11,876 | Common Stock |
| Mark A. Velleca | Director | Grant, award, or other acquisition of securities at price $ 2.10 per share. | 16 Jun 2023 | 8,929 | 41,314 (0%) | 0% | 2.1 | 18,751 | Common Stock |
| Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Garry E. Menzel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Samarth Kulkarni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Mark A. Velleca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Alexander Mayweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 1.67 per share. | 16 Mar 2023 | 6,437 | 22,653 (0%) | 0% | 1.7 | 10,750 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 1.67 per share. | 16 Mar 2023 | 7,111 | 35,115 (0%) | 0% | 1.7 | 11,875 | Common Stock |
| Mark A. Velleca | Director | Grant, award, or other acquisition of securities at price $ 1.67 per share. | 16 Mar 2023 | 11,228 | 32,385 (0%) | 0% | 1.7 | 18,751 | Common Stock |
| David M. Epstein | Director, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 420,000 | 420,000 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Sergey Yurasov | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Fang Ni | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Erika Jones | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Erika Jones | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 5,075 | 10,150 (0%) | 0% | 0 | Common Stock | |
| Robert Alexander Ingram | FORMER DIRECTOR | Grant, award, or other acquisition of securities at price $ 1.50 per share. | 16 Dec 2022 | 9,375 | 42,854 (0%) | 0% | 1.5 | 14,063 | Common Stock |
| Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 1.50 per share. | 16 Dec 2022 | 7,167 | 16,216 (0%) | 0% | 1.5 | 10,751 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 1.50 per share. | 16 Dec 2022 | 7,917 | 28,004 (0%) | 0% | 1.5 | 11,876 | Common Stock |
| Mark A. Velleca | Director | Grant, award, or other acquisition of securities at price $ 1.50 per share. | 16 Dec 2022 | 8,424 | 21,157 (0%) | 0% | 1.5 | 12,636 | Common Stock |
| Robert Alexander Ingram | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 16 Sep 2022 | 6,584 | 33,479 (0%) | 0% | 2.6 | 17,250 | Common Stock |
| Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 16 Sep 2022 | 4,103 | 9,049 (0%) | 0% | 2.6 | 10,750 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 16 Sep 2022 | 4,532 | 20,087 (0%) | 0% | 2.6 | 11,874 | Common Stock |
| Mark A. Velleca | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 16 Sep 2022 | 4,294 | 12,733 (0%) | 0% | 2.6 | 11,250 | Common Stock |
| Fang Ni | SEE REMARKS | Purchase of securities on an exchange or from another person at price $ 2.44 per share. | 29 Jun 2022 | 25,000 | 69,026 (0%) | 0% | 2.4 | 61,018 | Common Stock |
| Robert Alexander Ingram | Director | Grant, award, or other acquisition of securities at price $ 2.03 per share. | 17 Jun 2022 | 8,498 | 26,895 (0%) | 0% | 2.0 | 17,251 | Common Stock |
| Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 2.03 per share. | 17 Jun 2022 | 4,946 | 4,946 (0%) | 0% | 2.0 | 10,040 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 2.03 per share. | 17 Jun 2022 | 5,850 | 15,555 (0%) | 0% | 2.0 | 11,876 | Common Stock |
| Mark A. Velleca | Director | Grant, award, or other acquisition of securities at price $ 2.03 per share. | 17 Jun 2022 | 5,542 | 8,439 (0%) | 0% | 2.0 | 11,250 | Common Stock |
| Robert Alexander Ingram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Garry E. Menzel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Samarth Kulkarni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Mark A. Velleca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Alexander Mayweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Wendy L. Dixon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Robert Alexander Ingram | Director | Grant, award, or other acquisition of securities at price $ 3.02 per share. | 18 Mar 2022 | 5,795 | 18,397 (0%) | 0% | 3.0 | 17,501 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 3.02 per share. | 18 Mar 2022 | 4,346 | 9,705 (0%) | 0% | 3.0 | 13,125 | Common Stock |
| Mark A. Velleca | Director | Grant, award, or other acquisition of securities at price $ 3.02 per share. | 18 Mar 2022 | 2,897 | 2,897 (0%) | 0% | 3.0 | 8,749 | Common Stock |
| David M. Epstein | Director, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Fang Ni | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Erika Jones | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 20,300 | 20,300 | - | - | Stock Option (Right to Buy) | |
| Erika Jones | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 5,075 | 5,075 (0%) | 0% | 0 | Common Stock | |
| Robert Alexander Ingram | Director | Grant, award, or other acquisition of securities at price $ 9.90 per share. | 17 Sep 2021 | 1,869 | 9,306 (0%) | 0% | 9.9 | 18,503 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 9.90 per share. | 17 Sep 2021 | 1,326 | 2,887 (0%) | 0% | 9.9 | 13,127 | Common Stock |
| Mark A. Velleca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Robert Alexander Ingram | Director | Grant, award, or other acquisition of securities at price $ 12.95 per share. | 18 Jun 2021 | 1,255 | 7,437 (0%) | 0% | 12.9 | 16,252 | Common Stock |
| Robert Alexander Ingram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Garry E. Menzel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 12.95 per share. | 18 Jun 2021 | 1,014 | 1,561 (0%) | 0% | 12.9 | 13,131 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Samarth Kulkarni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Alexander Mayweg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Rajeev Shah | Director | Other type of transaction at price $ 24.01 per share. | 20 May 2021 | 443 | 0 (0%) | 0% | 24.0 | 10,636 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 26.11 per share. | 12 May 2021 | 1,161 | 11,317 (0%) | 0% | 26.1 | 30,309 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 4,078 | 160,474 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 28.21 per share. | 12 May 2021 | 351 | 8,400 (0%) | 0% | 28.2 | 9,900 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 27.90 per share. | 12 May 2021 | 2,566 | 8,751 (0%) | 0% | 27.9 | 71,596 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 12 May 2021 | 4,078 | 12,478 (0%) | 0% | 3.2 | 13,050 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 03 May 2021 | 2,500 | 3,200 (0%) | 0% | 26.6 | 66,602 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 2,500 | 163,609 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 03 May 2021 | 2,500 | 5,700 (0%) | 0% | 10.9 | 27,150 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 12 Apr 2021 | 4,078 | 8,400 (0%) | 0% | 25 | 101,950 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2021 | 179,915 | 164,552 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 12 Apr 2021 | 4,078 | 12,478 (0%) | 0% | 3.2 | 13,050 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.54 per share. | 05 Apr 2021 | 2,500 | 3,200 (0%) | 0% | 25.5 | 63,848 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 2,500 | 166,109 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 05 Apr 2021 | 2,500 | 5,700 (0%) | 0% | 10.9 | 27,150 | Common Stock |
| Rajeev Shah | Director | Other type of transaction at price $ 24.26 per share. | 01 Apr 2021 | 353,814 | 2,277,978 (6%) | 0% | 24.3 | 8,583,528 | Common Stock |
| Robert Alexander Ingram | Director | Grant, award, or other acquisition of securities at price $ 24.01 per share. | 18 Mar 2021 | 677 | 6,182 (0%) | 0% | 24.0 | 16,255 | Common Stock |
| Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 24.01 per share. | 18 Mar 2021 | 547 | 547 (0%) | 0% | 24.0 | 13,133 | Common Stock |
| Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 24.01 per share. | 18 Mar 2021 | 443 | 443 (0%) | 0% | 24.0 | 10,636 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 12 Mar 2021 | 4,078 | 12,478 (0%) | 0% | 3.2 | 13,050 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 4,078 | 168,630 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 26.36 per share. | 12 Mar 2021 | 4,078 | 8,400 (0%) | 0% | 26.4 | 107,493 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 03 Mar 2021 | 2,500 | 5,700 (0%) | 0% | 10.9 | 27,150 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 2,500 | 168,609 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 26.57 per share. | 03 Mar 2021 | 884 | 3,200 (0%) | 0% | 26.6 | 23,484 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 03 Mar 2021 | 1,616 | 4,084 (0%) | 0% | 25.9 | 41,778 | Common Stock |
| David M. Epstein | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Rachel Humphrey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Thomas Leggett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 27.19 per share. | 12 Feb 2021 | 3,771 | 8,707 (0%) | 0% | 27.2 | 102,533 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 4,078 | 172,708 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 27.66 per share. | 12 Feb 2021 | 307 | 8,400 (0%) | 0% | 27.7 | 8,492 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 12 Feb 2021 | 4,078 | 12,478 (0%) | 0% | 3.2 | 13,050 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.35 per share. | 03 Feb 2021 | 2,500 | 3,200 (0%) | 0% | 25.4 | 63,375 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 2,500 | 171,109 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 03 Feb 2021 | 2,500 | 5,700 (0%) | 0% | 10.9 | 27,150 | Common Stock |
| Kapil Dhingra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 29,842 | 29,842 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 30.50 per share. | 12 Jan 2021 | 1,669 | 16,261 (0%) | 0% | 30.5 | 50,912 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2021 | 7,500 | 71,251 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2021 | 4,078 | 176,786 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 36.00 per share. | 12 Jan 2021 | 7,511 | 8,400 (0%) | 0% | 36.0 | 270,395 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 34.13 per share. | 12 Jan 2021 | 100 | 15,911 (0%) | 0% | 34.1 | 3,413 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 32.50 per share. | 12 Jan 2021 | 103 | 16,011 (0%) | 0% | 32.5 | 3,347 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 31.90 per share. | 12 Jan 2021 | 147 | 16,114 (0%) | 0% | 31.9 | 4,690 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 29.92 per share. | 12 Jan 2021 | 2,048 | 17,930 (0%) | 0% | 29.9 | 61,284 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 12 Jan 2021 | 7,500 | 19,978 (0%) | 0% | 10.9 | 81,450 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 12 Jan 2021 | 4,078 | 12,478 (0%) | 0% | 3.2 | 13,050 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 08 Jan 2021 | 3,000 | 3,000 (0%) | 0% | 10.9 | 32,580 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2021 | 3,000 | 218,171 | - | - | Stock Option (Right to Buy) | |
| Thomas Leggett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.94 per share. | 08 Jan 2021 | 3,000 | 0 (0%) | 0% | 33.9 | 101,820 | Common Stock |
| David M. Epstein | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 31.80 per share. | 04 Jan 2021 | 2,015 | 696,423 (1%) | 0% | 31.8 | 64,075 | Common Stock |
| David M. Epstein | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.42 per share. | 04 Jan 2021 | 3,000 | 708,423 (1%) | 0% | 6.4 | 19,260 | Common Stock |
| David M. Epstein | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 30.99 per share. | 04 Jan 2021 | 9,985 | 698,438 (1%) | 0% | 31.0 | 309,430 | Common Stock |
| David M. Epstein | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 3,000 | 230,116 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 2,500 | 173,609 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.78 per share. | 04 Jan 2021 | 537 | 3,200 (0%) | 0% | 31.8 | 17,065 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.31 per share. | 04 Jan 2021 | 1,963 | 3,737 (0%) | 0% | 31.3 | 61,460 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 04 Jan 2021 | 2,500 | 5,700 (0%) | 0% | 10.9 | 27,150 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 5,400 | 180,864 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 28 Dec 2020 | 5,400 | 8,400 (0%) | 0% | 3.2 | 17,280 | Common Stock |
| Robert Alexander Ingram | Director | Grant, award, or other acquisition of securities at price $ 34.29 per share. | 15 Dec 2020 | 505 | 5,505 (0%) | 0% | 34.3 | 17,316 | Common Stock |
| David M. Epstein | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.42 per share. | 15 Dec 2020 | 2,500 | 705,423 (1%) | 0% | 6.4 | 16,050 | Common Stock |
| David M. Epstein | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 2,500 | 233,116 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 15 Dec 2020 | 3,200 | 3,200 (0%) | 0% | 10.9 | 34,752 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 3,200 | 176,109 | - | - | Stock Option (Right to Buy) | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Dec 2020 | 310 | 310 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Dec 2020 | 307 | 307 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Dec 2020 | 310 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Dec 2020 | 20,784 | 822,140 (2%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Dec 2020 | 11 | 21,851 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Dec 2020 | 307 | 0 (0%) | 0% | 0 | Common Stock | |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 4,078 | 186,264 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 34.95 per share. | 14 Dec 2020 | 4,078 | 3,000 (0%) | 0% | 34.9 | 142,522 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 14 Dec 2020 | 4,078 | 7,078 (0%) | 0% | 3.2 | 13,050 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.27 per share. | 08 Dec 2020 | 1,059 | 1,941 (0%) | 0% | 33.3 | 35,233 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2020 | 3,000 | 221,171 | - | - | Stock Option (Right to Buy) | |
| Thomas Leggett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 34.05 per share. | 08 Dec 2020 | 1,941 | 0 (0%) | 0% | 34.1 | 66,094 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 08 Dec 2020 | 3,000 | 3,000 (0%) | 0% | 10.9 | 32,580 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.42 per share. | 03 Dec 2020 | 2,500 | 0 (0%) | 0% | 32.4 | 81,055 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2020 | 2,500 | 179,309 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 03 Dec 2020 | 2,500 | 2,500 (0%) | 0% | 10.9 | 27,150 | Common Stock |
| David M. Epstein | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 32.64 per share. | 01 Dec 2020 | 10,923 | 704,000 (1%) | 0% | 32.6 | 356,553 | Common Stock |
| David M. Epstein | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 3,000 | 235,616 | - | - | Stock Option (Right to Buy) | |
| David M. Epstein | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 33.45 per share. | 01 Dec 2020 | 1,077 | 702,923 (1%) | 0% | 33.4 | 36,021 | Common Stock |
| David M. Epstein | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.42 per share. | 01 Dec 2020 | 3,000 | 714,923 (1%) | 0% | 6.4 | 19,260 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 6,797 | 6,797 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 15 | 21,840 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 463 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 463 | 463 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 467 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 467 | 467 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 31,175 | 842,924 (2%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.16 per share. | 27 Nov 2020 | 200 | 874,099 (2%) | 0% | 34.2 | 6,833 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.13 per share. | 27 Nov 2020 | 10,193 | 874,299 (2%) | 0% | 33.1 | 337,680 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 2,256 | 21,825 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 6,797 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 7,880 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 7,880 | 7,880 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Nov 2020 | 394,000 | 3,947,941 (10%) | 1% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 476,659 | 4,341,941 (12%) | 1% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 1,164 | 19,569 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 3,316 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 2,488 | 3,316 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 46,121 | 380,942 (1%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 828 | 828 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 154,671 | 1,277,541 (3%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 43 | 18,405 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 1,258 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 1,258 | 1,258 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 1,269 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 1,269 | 1,269 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 84,462 | 884,492 (2%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 2,728 | 18,362 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 8,223 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 8,223 | 8,223 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 9,533 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 9,533 | 9,533 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.01 per share. | 19 Nov 2020 | 114,854 | 4,818,600 (13%) | 0% | 33.0 | 3,791,331 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.01 per share. | 19 Nov 2020 | 15,163 | 968,954 (2%) | 0% | 33.0 | 500,531 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 17 Nov 2020 | 63 | 984,117 (2%) | 0% | 33.1 | 2,085 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.05 per share. | 17 Nov 2020 | 489 | 984,180 (2%) | 0% | 33.0 | 16,161 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.09 per share. | 17 Nov 2020 | 473 | 4,933,454 (13%) | 0% | 33.1 | 15,653 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.05 per share. | 17 Nov 2020 | 3,705 | 4,933,927 (13%) | 0% | 33.0 | 122,450 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.53 per share. | 13 Nov 2020 | 198 | 984,692 (2%) | 0% | 34.5 | 6,837 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.01 per share. | 13 Nov 2020 | 177 | 4,937,632 (13%) | 0% | 33.0 | 5,843 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 13 Nov 2020 | 23 | 984,669 (2%) | 0% | 33 | 759 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.53 per share. | 13 Nov 2020 | 1,502 | 4,937,809 (13%) | 0% | 34.5 | 51,865 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.32 per share. | 13 Nov 2020 | 2,473 | 4,939,311 (13%) | 0% | 33.3 | 82,388 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.31 per share. | 13 Nov 2020 | 327 | 984,890 (2%) | 0% | 33.3 | 10,894 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 12 Nov 2020 | 4,078 | 7,078 (0%) | 0% | 3.2 | 13,050 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2020 | 4,078 | 190,342 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 12 Nov 2020 | 250 | 3,000 (0%) | 0% | 35.0 | 8,752 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 34.24 per share. | 12 Nov 2020 | 2,261 | 3,250 (0%) | 0% | 34.2 | 77,418 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 33.46 per share. | 12 Nov 2020 | 1,567 | 5,511 (0%) | 0% | 33.5 | 52,437 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 35.15 per share. | 11 Nov 2020 | 47 | 985,217 (2%) | 0% | 35.1 | 1,652 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 11 Nov 2020 | 524 | 986,512 (2%) | 0% | 33.5 | 17,542 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 1,502 | 15,634 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 4,282 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 3,211 | 4,282 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 59,534 | 427,063 (1%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 1,071 | 1,071 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 199,652 | 1,432,212 (3%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 3,954 | 14,132 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 11,918 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 11,918 | 11,918 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 13,816 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 13,816 | 13,816 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 11 Nov 2020 | 690,814 | 4,955,563 (13%) | 1% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.39 per share. | 11 Nov 2020 | 9,450 | 4,942,137 (13%) | 0% | 34.4 | 325,012 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 11 Nov 2020 | 3,976 | 4,951,587 (13%) | 0% | 33.5 | 133,106 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.39 per share. | 11 Nov 2020 | 1,248 | 985,264 (2%) | 0% | 34.4 | 42,922 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 35.15 per share. | 11 Nov 2020 | 353 | 4,941,784 (13%) | 0% | 35.2 | 12,408 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2020 | 5,000 | 181,809 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 34.90 per share. | 11 Nov 2020 | 5,000 | 0 (0%) | 0% | 34.9 | 174,500 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 11 Nov 2020 | 5,000 | 5,000 (0%) | 0% | 10.9 | 54,300 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.14 per share. | 10 Nov 2020 | 1,642 | 988,507 (2%) | 0% | 34.1 | 56,064 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.94 per share. | 10 Nov 2020 | 9,027 | 5,646,377 (15%) | 0% | 34.9 | 315,378 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.86 per share. | 10 Nov 2020 | 2,119 | 5,655,404 (15%) | 0% | 33.9 | 71,748 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.94 per share. | 10 Nov 2020 | 1,191 | 987,036 (2%) | 0% | 34.9 | 41,610 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.86 per share. | 10 Nov 2020 | 280 | 988,227 (2%) | 0% | 33.9 | 9,481 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.14 per share. | 10 Nov 2020 | 12,433 | 5,657,523 (15%) | 0% | 34.1 | 424,510 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 10 Nov 2020 | 11,388 | 5,669,956 (15%) | 0% | 33.5 | 381,245 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 10 Nov 2020 | 1,503 | 990,149 (2%) | 0% | 33.5 | 50,317 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.96 per share. | 09 Nov 2020 | 3,000 | 0 (0%) | 0% | 33.0 | 98,892 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 3,000 | 224,171 | - | - | Stock Option (Right to Buy) | |
| Thomas Leggett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 09 Nov 2020 | 3,000 | 3,000 (0%) | 0% | 10.9 | 32,580 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.13 per share. | 06 Nov 2020 | 2,738 | 5,686,909 (15%) | 0% | 33.1 | 90,706 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.06 per share. | 06 Nov 2020 | 5,565 | 5,681,344 (15%) | 0% | 33.1 | 183,954 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.06 per share. | 06 Nov 2020 | 735 | 991,652 (2%) | 0% | 33.1 | 24,296 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.13 per share. | 06 Nov 2020 | 362 | 992,387 (2%) | 0% | 33.1 | 11,993 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.14 per share. | 04 Nov 2020 | 292 | 993,781 (2%) | 0% | 33.1 | 9,676 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.15 per share. | 04 Nov 2020 | 7,816 | 5,689,647 (15%) | 0% | 33.1 | 259,079 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.15 per share. | 04 Nov 2020 | 1,032 | 992,749 (2%) | 0% | 33.1 | 34,208 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.14 per share. | 04 Nov 2020 | 2,208 | 5,697,463 (15%) | 0% | 33.1 | 73,164 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.95 per share. | 03 Nov 2020 | 2,500 | 0 (0%) | 0% | 31.9 | 79,873 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 2,500 | 186,809 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 03 Nov 2020 | 2,500 | 2,500 (0%) | 0% | 10.9 | 27,150 | Common Stock |
| David M. Epstein | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 31.13 per share. | 02 Nov 2020 | 11,917 | 712,006 (1%) | 0% | 31.1 | 371,011 | Common Stock |
| David M. Epstein | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 3,000 | 238,616 | - | - | Stock Option (Right to Buy) | |
| David M. Epstein | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 31.88 per share. | 02 Nov 2020 | 83 | 711,923 (1%) | 0% | 31.9 | 2,646 | Common Stock |
| David M. Epstein | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.42 per share. | 02 Nov 2020 | 3,000 | 723,923 (2%) | 0% | 6.4 | 19,260 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.03 per share. | 26 Oct 2020 | 707 | 5,699,671 (15%) | 0% | 33.0 | 23,354 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.03 per share. | 26 Oct 2020 | 93 | 994,073 (2%) | 0% | 33.0 | 3,072 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.30 per share. | 26 Oct 2020 | 7,158 | 5,700,378 (15%) | 0% | 33.3 | 238,394 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.30 per share. | 26 Oct 2020 | 945 | 994,166 (2%) | 0% | 33.3 | 31,473 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.03 per share. | 15 Oct 2020 | 327 | 996,621 (2%) | 0% | 33.0 | 10,802 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.43 per share. | 15 Oct 2020 | 3,739 | 5,707,536 (15%) | 0% | 33.4 | 124,998 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.43 per share. | 15 Oct 2020 | 494 | 995,111 (2%) | 0% | 33.4 | 16,515 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.57 per share. | 15 Oct 2020 | 7,697 | 5,711,275 (15%) | 0% | 33.6 | 258,410 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.57 per share. | 15 Oct 2020 | 1,016 | 995,605 (2%) | 0% | 33.6 | 34,110 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.03 per share. | 15 Oct 2020 | 2,473 | 5,718,972 (15%) | 0% | 33.0 | 81,694 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.39 per share. | 13 Oct 2020 | 10,370 | 5,726,304 (15%) | 0% | 33.4 | 346,271 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.09 per share. | 13 Oct 2020 | 4,859 | 5,721,445 (15%) | 0% | 33.1 | 160,787 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.09 per share. | 13 Oct 2020 | 642 | 996,948 (2%) | 0% | 33.1 | 21,244 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.39 per share. | 13 Oct 2020 | 1,369 | 997,590 (2%) | 0% | 33.4 | 45,713 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 33.75 per share. | 12 Oct 2020 | 295 | 3,000 (0%) | 0% | 33.8 | 9,957 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 12 Oct 2020 | 4,078 | 7,078 (0%) | 0% | 3.2 | 13,050 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2020 | 4,078 | 194,420 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 32.61 per share. | 12 Oct 2020 | 3,783 | 3,295 (0%) | 0% | 32.6 | 123,373 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.25 per share. | 08 Oct 2020 | 1,027 | 1,000,571 (2%) | 0% | 33.2 | 34,145 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.68 per share. | 08 Oct 2020 | 1,122 | 999,449 (2%) | 0% | 33.7 | 37,790 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.25 per share. | 08 Oct 2020 | 7,774 | 5,748,886 (16%) | 0% | 33.2 | 258,461 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.68 per share. | 08 Oct 2020 | 8,502 | 5,740,384 (15%) | 0% | 33.7 | 286,352 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.67 per share. | 08 Oct 2020 | 443 | 999,006 (2%) | 0% | 33.7 | 14,914 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.67 per share. | 08 Oct 2020 | 3,357 | 5,737,027 (15%) | 0% | 33.7 | 113,018 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.11 per share. | 08 Oct 2020 | 47 | 998,959 (2%) | 0% | 33.1 | 1,556 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.11 per share. | 08 Oct 2020 | 353 | 5,736,674 (15%) | 0% | 33.1 | 11,687 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2020 | 3,000 | 227,171 | - | - | Stock Option (Right to Buy) | |
| Thomas Leggett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.53 per share. | 08 Oct 2020 | 3,000 | 0 (0%) | 0% | 33.5 | 100,576 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 08 Oct 2020 | 3,000 | 3,000 (0%) | 0% | 10.9 | 32,580 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 3,098 | 4,131 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 57,424 | 486,597 (1%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 1,033 | 1,033 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 192,576 | 1,631,864 (4%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 22 | 8,729 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 588 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 588 | 588 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 593 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 593 | 593 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 39,608 | 1,001,598 (2%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.56 per share. | 06 Oct 2020 | 24,590 | 5,756,660 (16%) | 0% | 33.6 | 825,154 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.56 per share. | 06 Oct 2020 | 3,246 | 1,041,206 (2%) | 0% | 33.6 | 108,924 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.26 per share. | 06 Oct 2020 | 2,110 | 1,044,452 (2%) | 0% | 33.3 | 70,176 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.26 per share. | 06 Oct 2020 | 15,980 | 5,781,250 (16%) | 0% | 33.3 | 531,477 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 1,449 | 10,178 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Oct 2020 | 4,131 | 0 (0%) | 0% | 0 | Common Stock | |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.20 per share. | 05 Oct 2020 | 2,273 | 227 (0%) | 0% | 31.2 | 70,927 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2020 | 2,500 | 189,309 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.99 per share. | 05 Oct 2020 | 227 | 0 (0%) | 0% | 32.0 | 7,261 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 05 Oct 2020 | 2,500 | 2,500 (0%) | 0% | 10.9 | 27,150 | Common Stock |
| David M. Epstein | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 30.33 per share. | 01 Oct 2020 | 12,000 | 720,923 (2%) | 0% | 30.3 | 363,962 | Common Stock |
| David M. Epstein | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 3,000 | 241,616 | - | - | Stock Option (Right to Buy) | |
| David M. Epstein | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.42 per share. | 01 Oct 2020 | 3,000 | 732,923 (2%) | 0% | 6.4 | 19,260 | Common Stock |
| Robert Alexander Ingram | Director | Purchase of securities on an exchange or from another person at price $ 30.46 per share. | 30 Sep 2020 | 5,000 | 5,000 (0%) | 0% | 30.5 | 152,285 | Common Stock |
| Robert Alexander Ingram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2020 | 29,842 | 29,842 | - | - | Stock Option (Right to Buy) | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 1,187 | 1,187 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 1,449 | 8,707 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 4,131 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 3,098 | 4,131 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 57,424 | 544,021 (1%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 1,033 | 1,033 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 192,576 | 1,824,440 (5%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 42 | 7,258 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 1,177 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 1,177 | 1,177 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 1,187 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 79,216 | 1,046,562 (2%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 2,289 | 7,216 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 6,901 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 6,901 | 6,901 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 8,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 8,000 | 8,000 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Sep 2020 | 400,000 | 5,797,230 (16%) | 1% | 0 | Common Stock | |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 14 Sep 2020 | 4,078 | 7,078 (0%) | 0% | 3.2 | 13,050 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 4,078 | 198,498 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 32.55 per share. | 14 Sep 2020 | 207 | 3,000 (0%) | 0% | 32.6 | 6,738 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 31.42 per share. | 14 Sep 2020 | 1,186 | 3,207 (0%) | 0% | 31.4 | 37,267 | Common Stock |
| Brent Hatzis-Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 30.76 per share. | 14 Sep 2020 | 2,685 | 4,393 (0%) | 0% | 30.8 | 82,578 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.00 per share. | 14 Sep 2020 | 3,000 | 0 (0%) | 0% | 31 | 93,000 | Common Stock |
| Thomas Leggett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 3,000 | 230,171 | - | - | Stock Option (Right to Buy) | |
| Thomas Leggett | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 14 Sep 2020 | 3,000 | 3,000 (0%) | 0% | 10.9 | 32,580 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.95 per share. | 03 Sep 2020 | 142 | 2,358 (0%) | 0% | 29.0 | 4,111 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2020 | 2,500 | 191,809 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 29.63 per share. | 03 Sep 2020 | 2,358 | 0 (0%) | 0% | 29.6 | 69,877 | Common Stock |
| Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 03 Sep 2020 | 2,500 | 2,500 (0%) | 0% | 10.9 | 27,150 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Aug 2020 | 1,718 | 4,927 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Aug 2020 | 5,176 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Aug 2020 | 5,176 | 5,176 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Aug 2020 | 6,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Aug 2020 | 6,000 | 6,000 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Aug 2020 | 300,000 | 6,197,230 (17%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2020 | 6,000 | 6,000 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2020 | 300,000 | 6,497,230 (18%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2020 | 1,718 | 3,209 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2020 | 5,176 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2020 | 5,176 | 5,176 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Aug 2020 | 6,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.08 per share. | 10 Aug 2020 | 883 | 1,125,778 (3%) | 0% | 33.1 | 29,211 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.04 per share. | 10 Aug 2020 | 725 | 1,126,661 (3%) | 0% | 33.0 | 23,953 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.08 per share. | 10 Aug 2020 | 6,692 | 6,797,230 (18%) | 0% | 33.1 | 221,380 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.04 per share. | 10 Aug 2020 | 5,492 | 6,803,922 (18%) | 0% | 33.0 | 181,446 | Common Stock |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 57,424 | 601,445 (1%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 42 | 1,491 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 1,177 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 1,177 | 1,177 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 1,187 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 1,187 | 1,187 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 79,217 | 1,127,386 (3%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 1,449 | 1,449 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 4,131 | 0 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 3,098 | 4,131 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 1,033 | 1,033 (0%) | 0% | 0 | Common Stock | |
| Bradley J. Bolzon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jul 2020 | 192,576 | 2,017,016 (5%) | 0% | 0 | Common Stock | |
| David M. Epstein | Director, See Remarks | 03 Feb 2020 | 13,136 | 0 | - | - | Series B Preferred Stock | ||
| David M. Epstein | Director, See Remarks | 03 Feb 2020 | 69,636 | 0 | - | - | Series A Preferred Stock | ||
| David M. Epstein | Director, See Remarks | 03 Feb 2020 | 242,904 | 725,569 (2%) | 0% | - | Common Stock | ||
| David M. Epstein | Director, See Remarks | 03 Feb 2020 | 23,090 | 23,090 (0%) | 0% | - | Common Stock | ||
| David M. Epstein | Director, See Remarks | 03 Feb 2020 | 4,354 | 729,923 (2%) | 0% | - | Common Stock | ||
| David M. Epstein | Director, See Remarks | 03 Feb 2020 | 732,560 | 0 | - | - | Series A Preferred Stock | ||
| Garry E. Menzel | Director | 03 Feb 2020 | 156,297 | 0 | - | - | Series A Preferred Stock | ||
| Garry E. Menzel | Director | 03 Feb 2020 | 51,825 | 51,825 (0%) | 0% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 454,548 | 6,413,332 (17%) | 1% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 810,522 | 810,522 (2%) | 2% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 503,327 | 1,780,438 (4%) | 1% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 150,085 | 530,902 (1%) | 0% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 653,412 | 5,958,784 (16%) | 1% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 1,277,111 | 1,277,111 (3%) | 3% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 380,817 | 380,817 (1%) | 1% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 1,148,474 | 0 | - | - | Series A Preferred Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 15,000,000 | 0 | - | - | Series A Preferred Stock | ||
| Bradley J. Bolzon | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 03 Feb 2020 | 396,081 | 1,206,603 (3%) | 1% | 19 | 7,525,539 | Common Stock |
| Bradley J. Bolzon | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 03 Feb 2020 | 396,082 | 6,809,414 (18%) | 1% | 19 | 7,525,558 | Common Stock |
| Bradley J. Bolzon | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 03 Feb 2020 | 23,560 | 658,869 (1%) | 0% | 19 | 447,640 | Common Stock |
| Bradley J. Bolzon | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 03 Feb 2020 | 79,013 | 2,209,592 (6%) | 0% | 19 | 1,501,247 | Common Stock |
| Bradley J. Bolzon | Director | 03 Feb 2020 | 350,141 | 2,130,579 (5%) | 0% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 104,407 | 635,309 (1%) | 0% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 1,370,833 | 0 | - | - | Series C Preferred Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 2,444,382 | 0 | - | - | Series C Preferred Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 1,517,940 | 0 | - | - | Series B Preferred Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 452,630 | 0 | - | - | Series B Preferred Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 1,970,572 | 0 | - | - | Series B Preferred Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 3,851,526 | 0 | - | - | Series A Preferred Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 4,973,787 | 5,305,372 (14%) | 13% | - | Common Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 1,055,960 | 0 | - | - | Series C Preferred Stock | ||
| Bradley J. Bolzon | Director | 03 Feb 2020 | 314,873 | 0 | - | - | Series C Preferred Stock | ||
| Ali Behbahani | Director | 03 Feb 2020 | 2,176,957 | 2,176,957 (6%) | 6% | - | Common Stock | ||
| Ali Behbahani | Director | 03 Feb 2020 | 471,800 | 2,648,757 (7%) | 1% | - | Common Stock | ||
| Ali Behbahani | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 03 Feb 2020 | 800,000 | 3,448,757 (9%) | 2% | 19 | 15,200,000 | Common Stock |
| Ali Behbahani | Director | 03 Feb 2020 | 6,565,290 | 0 | - | - | Series B Preferred Stock | ||
| Ali Behbahani | Director | 03 Feb 2020 | 1,422,862 | 0 | - | - | Series C Preferred Stock | ||
| Brent Hatzis-Schoch | See Remarks | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 03 Feb 2020 | 3,000 | 3,000 (0%) | 0% | 19 | 57,000 | Common Stock |
| Rajeev Shah | Director | 03 Feb 2020 | 30,526 | 217,275 (0%) | 0% | - | Common Stock | ||
| Rajeev Shah | Director | 03 Feb 2020 | 92,063 | 0 | - | - | Series C Preferred Stock | ||
| Rajeev Shah | Director | 03 Feb 2020 | 213,429 | 0 | - | - | Series C Preferred Stock | ||
| Rajeev Shah | Director | 03 Feb 2020 | 548,224 | 0 | - | - | Series C Preferred Stock | ||
| Rajeev Shah | Director | 03 Feb 2020 | 563,204 | 0 | - | - | Series B Preferred Stock | ||
| Rajeev Shah | Director | 03 Feb 2020 | 492,643 | 0 | - | - | Series B Preferred Stock | ||
| Rajeev Shah | Director | 03 Feb 2020 | 2,885,295 | 0 | - | - | Series B Preferred Stock | ||
| Rajeev Shah | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 03 Feb 2020 | 136,539 | 353,814 (0%) | 0% | 19 | 2,594,241 | Common Stock |
| Rajeev Shah | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 03 Feb 2020 | 77,803 | 311,926 (0%) | 0% | 19 | 1,478,257 | Common Stock |
| Rajeev Shah | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 03 Feb 2020 | 785,658 | 1,924,164 (5%) | 2% | 19 | 14,927,502 | Common Stock |
| Rajeev Shah | Director | 03 Feb 2020 | 70,770 | 234,123 (0%) | 0% | - | Common Stock | ||
| Rajeev Shah | Director | 03 Feb 2020 | 181,783 | 1,138,506 (3%) | 0% | - | Common Stock | ||
| Rajeev Shah | Director | 03 Feb 2020 | 186,749 | 186,749 (0%) | 0% | - | Common Stock | ||
| Rajeev Shah | Director | 03 Feb 2020 | 163,353 | 163,353 (0%) | 0% | - | Common Stock | ||
| Rajeev Shah | Director | 03 Feb 2020 | 956,723 | 956,723 (2%) | 2% | - | Common Stock | ||
| David M. Epstein | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2020 | 278,532 | 278,532 | - | - | Stock Option (Right to Buy) | |
| Brent Hatzis-Schoch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2020 | 78,751 | 78,751 | - | - | Stock Option (Right to Buy) | |
| Thomas Leggett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2020 | 55,540 | 55,540 | - | - | Stock Option (Right to Buy) | |
| Christopher D. Roberts | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2020 | 54,711 | 54,711 | - | - | Stock Option (Right to Buy) |